Clinical Trials

We have both prevention and symptomatic trials. Our current prevention trial is listed at the top, followed by our symptomatic trials.

The Aware Study assesses the effectiveness and safety of an investigational medication (monoclonal antibody - passive vaccine - that removes abnormal tau protein from the brain) to determine whether it can reduce symptoms in early Alzheimer's disease (AD).

Attachment:

The Mission AD study is assessing the effectiveness and safety of an investigational medication (a "BACE" inhibitor, which stops the formation of the building blocks of amyloid in the brain) to improve the symptoms of Alzheimer's disease.

Are you having memory problems or trouble thinking clearly? Have you been diagnosed with Mild Cognitive Impairment (MCI) or mild dementia due to Alzheimer’s disease (early AD)? Are you interested in participating in a clinical trial to help better understand how to slow the progression of Alzheimer’s disease and to evaluate an investigational treatment for individuals with early AD?

Are you having memory problems or trouble thinking clearly? Have you been diagnosed with Mild Cognitive Impairment (MCI) or dementia due to early Alzheimer’s disease (AD)? Are you interested in participating in a clinical trial to help better understand if a new medication may slow the progression of Alzheimer’s disease and evaluate a new potential treatment for individuals with early AD.